Informations:
Erreur:
ID
38025
Description
Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01483300
Lien
https://clinicaltrials.gov/show/NCT01483300
Mots-clés
Versions (1)
- 09/09/2019 09/09/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
9 septembre 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Breast Cancer NCT01483300
Eligibility Breast Cancer NCT01483300
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01483300
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Secondary malignant neoplasm of female breast
Item
histologically confirmed metastatic breast cancer
boolean
C0346993 (UMLS CUI [1])
Disease Progression During First line Prior Chemotherapy | Disease Progression Post First line Prior Chemotherapy
Item
disease progression during or after previous 1st line chemotherapy
boolean
C0242656 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C1708063 (UMLS CUI [1,3])
C1514457 (UMLS CUI [1,4])
C0242656 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C1708063 (UMLS CUI [2,3])
C1514457 (UMLS CUI [2,4])
C0347984 (UMLS CUI [1,2])
C1708063 (UMLS CUI [1,3])
C1514457 (UMLS CUI [1,4])
C0242656 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C1708063 (UMLS CUI [2,3])
C1514457 (UMLS CUI [2,4])
Second line Chemotherapy Scheduled
Item
scheduled to receive 2nd line chemotherapy.
boolean
C1710038 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
Measurable Disease | Lesion Quantity Measurable Linear
Item
measurable disease, defined as a least one lesion that can be accurately measured in at least one dimension
boolean
C1513041 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1513040 (UMLS CUI [2,3])
C0205132 (UMLS CUI [2,4])
C0221198 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1513040 (UMLS CUI [2,3])
C0205132 (UMLS CUI [2,4])
Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of greater than 6 months
boolean
C0023671 (UMLS CUI [1])
Prior Therapy Investigational New Drug
Item
previous treatment with one of the study drugs
boolean
C1514463 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
Cytotoxic Chemotherapy | Therapeutic radiology procedure
Item
application of other cytotoxic chemotherapy or radiotherapy
boolean
C0677881 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
Renal function Insufficient | Creatinine clearance measurement
Item
insufficent renal function (creatinine clearance < 60ml/min)
boolean
C0232804 (UMLS CUI [1,1])
C0231180 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
C0231180 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
Metastatic malignant neoplasm to brain Clinical Unstable
Item
clinically unstable brain metastasis
boolean
C0220650 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,3])
C0205210 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,3])
Pregnancy | Breast Feeding
Item
pregancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Cancer Other
Item
history of other malignancy within last 5 years.
boolean
C1707251 (UMLS CUI [1])